The epidemiology of tumor lysis syndrome is evolving with the introduction of newer therapies. The occurrence of tumor lysis syndrome has become a less predictable but increasingly important aspect of ...
Although tumor lysis syndrome may be dangerous and fatal if not treated early, experts note that it is a sign of successful treatment in patients with leukemia and lymphoma. Cancer treatment almost ...
Impact of the Affordable Care Act and Medicaid Expansion Among Patients With HIV-Associated Aggressive B-Cell Non-Hodgkin Lymphomas Venetoclax has made a significant impact in the treatment of chronic ...
Evaluating quality of life improvements in radiation cystitis and head and neck cancer patients following hyperbaric oxygen therapy. Longitudinal analysis of cancer symptom clusters and inflammatory ...
A pharmacist-led clinic achieved a 94.3% success rate in venetoclax ramp-up for patients with CLL, minimizing serious TLS incidents. Pharmacists independently managed TLS prophylaxis and drug ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results